Groups
Newman J, Thakur N, Peacock T P, Bialy D, Elrefaey A M E, Bogaardt C, Horton D L, Ho S, Kankeyan T, Carr C, Hoschler K, Barclay W S, Amirthalingam G, Brown K E, Charleston B, Bailey D (2022)
Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2
Nature Microbiology early view
Publisher’s version: https://doi.org/10.1038/s41564-022-01163-3
Spencer A J, Morris S, Ulaszewska M, Powers C, Kailath R, Bissett C, Truby A, Thakur N, Newman J, Allen E R, Rudiansyah I, Liu C, Dejnirattisai W, Mongkolsapaya J, Davies H, Donnellan F R, Pulido D, Peacock T P, Barclay W S, Bright H, Ren K, Screaton G, McTamney P, Bailey D, Gilbert S C, Lambe T (2022)
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies
eBioMedicine 77
Publisher’s version: https://doi.org/10.1016/j.ebiom.2022.103902
Newman J, Thakur N, Peacock T P, Bialy D, Elreafey A M E, Bogaardt C, Horton D L, Ho S, Kankeyan T, Carr C, Hoschler K, Barclay W S, Amirthalingam G, Brown K, Charleston B, Bailey D (2021)
Neutralising antibody activity against SARS-CoV-2 variants, including Omicron, in an elderly cohort vaccinated with BNT162b2
medRxiv
Publisher’s version: https://doi.org/10.1101/2021.12.23.21268293
Peacock T P, Brown J C, Zhou J, Thakur N, Newman J, Kugathasan R, Sukhova K, Kaforou M, Bailey D, Barclay W S (2022)
The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry
bioRxiv
Publisher’s version: https://doi.org/10.1101/2021.12.31.474653
Newman J, Rowlands D J, Tuthill T J (2021)
An engineered maturation cleavage provides a recombinant mimic of foot-and-mouth disease virus capsid assembly-disassembly
Life 11 (6) , 500
Publisher’s version: https://doi.org/10.3390/life11060500